5326612025-07-012025-09-305326612025-09-305326612025-03-315326612025-04-012025-09-305326612025-07-012025-09-30in-capmkt:OtherExpenses1Member5326612025-04-012025-09-30in-capmkt:OtherExpenses1Member5326612025-07-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15326612025-04-012025-09-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15326612025-07-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss15326612025-04-012025-09-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares532661RMLNOTLISTEDINE050H01012RANE (MADRAS) LIMITEDMain BoardEquity2025-04-012026-03-312025-11-042025-09-29INRCroresQuarterlySecond quarterSingle segmentThe Company operates only in one segment, namely, manufacture and marketing of components and providing technological services for Transportation industry.2025-11-0411:32:002025-11-0415:17:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated91931000004090000092340000005146500000591800000-358600000126390000015090000036510000017617000008921300000312700000-159000002968000000821000008210000002147000000000214700000-710000001437000000000276400000107.777.77007.777.773. The above financial results ... approved by the BoD … on November 04, 2025. <BR> 4. The above financial results have been prepared in accordance … Ind AS … <BR> 5. RML and its subsidiaries … is considered as the only operating segment of the Group. <BR> 6. Exceptional items in the above financial results include the following: <BR> - The Co incurred voluntary retirement expenditure amounting to Rs. 1.59 crores for QE September 30, 2025, Rs. 1.01 cr for Q1 and Rs. 2.60 crs for H1. <BR> - The Co has recognised income on insurance claim towards an overseas customer's product liability claim amounting to Rs. 4.25 crs and has incurred provision towards customer quality claims and merger related expenses aggregating to Rs. 4.50 crs for HY ended September 30, 2024. <BR> - The Co has primarily incurred merger related expenses including stamp duty charges, onetime warranty costs and expenditure towards VRS amounting to Rs. 12.99 crs for YE March 31, 2025 and Rs. 0.44 cr for the QE September 30, 2024. <BR> 7. The BoD of the Co in its meeting held on February 9, 2024, had approved the scheme of amalgamation ...with the relevant RoC on April 07, 2025. <BR> The amalgamation has been accounted in accordance with Pooling of interest method … The difference between the assets, liabilities, acquired reserves and shares transferred were transferred to Capital Reserves amounting to Rs. 3.59 crs during the YE March 31, 2025. <BR> Pursuant to the allotment of equity shares on April 23, 2025 in accordance with the share exchange ratio prescribed in the Scheme, the issued and paid up share capital of the Co stands increased to INR 27,63,71,370 comprising of 2,76,37,137 equity shares of INR 10 each fully paid up. <BR> 8. The Co has entered into an agreement with Canopy Living LLP A JV between Arihant Foundations & Housing Ltd and Prestige Estates Project Ltd to sell 3.48 acres of land in Velachery for an aggregate consideration of INR 361.18 crs. Pursuant to this agreement, the Co has received an advance of INR 115 crs till 30 September 2025. The Co currently owns a total land parcel of 4.50 acres in Velachery and it will retain the balance portion of 1.02 acres for constructing a new office. <BR> Accordingly, the carrying value of the said land, amounting to INR 0.02 cr, has been classified under Assets Held-for-Sale in accordance with Ind AS 105 Non-current assets held for sale and discontinued operations. <BR> 9. During the YE March 31, 2025, erstwhile REVL had elected to opt for the new tax regime under the IT Act, 1961 with effect from FY 2023-24 resulting in an additional tax expense of INR 14.20 crs including INR 5.93 crs on account of reversal of MAT credit due to remeasurement of the deferred tax asset net. <BR> 10. The .. financial results .. are also available on the SE websites and on the www.ranegroup.com. 2025-04-012025-09-30UnauditedConsolidated17999100000789000001807800000010271000000793800000-5800000002536100000321200000722200000344310000017507400000570600000-26000000544600000014460000014460000004000000000000400000000-8780000031220000000002764000001014.4714.470014.4714.47Other Expenses1761700000Other Expenses34431000006243700000972800000046300000514700000677000000001988000001988000008746000001220500000101391000005050700000073434000004208000001350000013200000356200000814710000007727000001397050000020000002410980000027640000065237000006800100000068001000007325000000004701000001202600000247900000004270000014932000007072200000327200000491180000052390000002496000000148072000006479000003614000000015816500000001730970000024109800000321200000-712500000-21710000002540000000-2750000002338000000-202200000072220000035900000-95400000482000000-124600000-19100000032900000000-6700000-9200000-5000000-6100000048360000000024580000002378000000000000092000009354000000000000000000000009900000011466000002303000000000000026734600000264377000004980000022110000030740000000-2814000001867000000186700000225200000411900000(i) Remeasurement gains/(losses) on defined benefit plans, net-93000000-93000000(i) Remeasurement gains/(losses) on defined benefit plans, net-94500000-94500000-24000000-24400000(i) Exchange differences on translating financial statements of foreign operations-2000000-2000000(i) Exchange differences on translating financial statements of foreign operations-17700000-1770000000-71000000-87800000